Total Payments
$16,939
2024 Payments
$146.65
Companies
15
Transactions
55
Payment Breakdown by Category
Consulting$14,785 (87.3%)
Food & Beverage$1,313 (7.7%)
Travel$841.22 (5.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,785 | 6 | 87.3% |
| Food and Beverage | $1,313 | 46 | 7.7% |
| Travel and Lodging | $841.22 | 3 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $8,355 | 13 | $0 (2023) |
| Boehringer Ingelheim International GmbH | $4,988 | 4 | $0 (2023) |
| Boehringer Ingelheim Italia S.p.A. | $2,588 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $474.91 | 18 | $0 (2024) |
| Circassia Pharmaceuticals Inc | $150.00 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $121.01 | 8 | $0 (2021) |
| NS Pharma, Inc. | $109.99 | 1 | $0 (2024) |
| Advanced Respiratory, Inc | $38.00 | 2 | $0 (2020) |
| Vapotherm Inc | $21.60 | 1 | $0 (2022) |
| Covis Pharma GmbH | $20.69 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $146.65 | 3 | NS Pharma, Inc. ($109.99) |
| 2023 | $4,772 | 4 | Boehringer Ingelheim International GmbH ($4,688) |
| 2022 | $8,490 | 9 | Boehringer Ingelheim Pharmaceuticals, Inc. ($8,169) |
| 2021 | $2,659 | 5 | Boehringer Ingelheim Italia S.p.A. ($2,588) |
| 2020 | $311.63 | 11 | AstraZeneca Pharmaceuticals LP ($175.26) |
| 2019 | $187.06 | 10 | AstraZeneca Pharmaceuticals LP ($105.09) |
| 2018 | $138.70 | 8 | AstraZeneca Pharmaceuticals LP ($69.39) |
| 2017 | $233.80 | 5 | Circassia Pharmaceuticals Inc ($150.00) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Respiratory | ||||||
| 04/24/2024 | NS Pharma, Inc. | VILTEPSO (Drug) | Food and Beverage | In-kind items and services | $109.99 | General |
| Category: PEDIATRIC NEUROLOGY | ||||||
| 11/30/2023 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $2,062.50 | General |
| Category: RESPIRATORY | ||||||
| 05/22/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $84.19 | General |
| 04/21/2023 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $1,087.50 | General |
| Category: RESPIRATORY | ||||||
| 03/30/2023 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $1,537.50 | General |
| Category: RESPIRATORY | ||||||
| 12/21/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $7,210.00 | General |
| Category: RESPIRATORY | ||||||
| 12/21/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Travel and Lodging | In-kind items and services | $140.00 | General |
| Category: RESPIRATORY | ||||||
| 12/21/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: RESPIRATORY | ||||||
| 12/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Travel and Lodging | In-kind items and services | $567.82 | General |
| Category: RESPIRATORY | ||||||
| 12/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Travel and Lodging | In-kind items and services | $133.40 | General |
| Category: RESPIRATORY | ||||||
| 12/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: RESPIRATORY | ||||||
| 11/30/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $75.28 | General |
| 10/26/2022 | Boehringer Ingelheim International GmbH | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: RESPIRATORY | ||||||
| 02/09/2022 | Vapotherm Inc | VAPOTHERM (Device) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2021 | Boehringer Ingelheim Italia S.p.A. | OFEV (Drug) | Consulting Fee | Cash or cash equivalent | $2,587.50 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $21.68 | General |
| 10/08/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: IMMUNOLOGY | ||||||
| 09/08/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Respiratory | ||||||
| 08/30/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Respiratory | ||||||
| 12/17/2020 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: IMMUNOLOGY | ||||||
| 11/30/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2020 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $8.09 | General |
| 08/10/2020 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Respiratory | ||||||
About Dr. Jonathan Popler, MD
Dr. Jonathan Popler, MD is a Pediatrics healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1154542389.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Popler, MD has received a total of $16,939 in payments from pharmaceutical and medical device companies, with $146.65 received in 2024. These payments were reported across 55 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($14,785).
Ad
Practice Information
- Specialty Pediatrics
- Location Atlanta, GA
- Active Since 05/02/2007
- Last Updated 06/06/2022
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1154542389
Products in Payments
- OFEV (Drug) $15,668
- FASENRA (Drug) $163.61
- NIOX VERO DEVICE (Device) $150.00
- NUCALA (Biological) $121.01
- VILTEPSO (Drug) $109.99
- SPIRIVA RESPIMAT (Drug) $102.18
- FASENRA (Biological) $74.81
- ALVESCO (Drug) $39.69
- The Vest System Model 105 Home Care (Device) $38.00
- SYMBICORT (Drug) $26.46
- VAPOTHERM (Device) $21.60
- SYNAGIS (Drug) $17.38
- SMARTVEST (Device) $15.34
- Xolair (Biological) $12.84
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Atlanta
Dr. Amir Ashrafi, M.d, M.D
Pediatrics — Payments: $784,061
Pediatrics $784,061
Karen Zimowski, Md, MD
Pediatrics — Payments: $137,038
Pediatrics $137,038
Satheesh Chonat, Md, MD
Pediatrics — Payments: $96,413
Pediatrics $96,413
Dr. Michael Goodman, Md, Mph, MD, MPH
Pediatrics — Payments: $77,369
Pediatrics $77,369
Lauren Middlebrooks, Md, MD
Pediatrics — Payments: $59,106
Pediatrics $59,106
Dr. Ross Fasano, M.d, M.D
Pediatrics — Payments: $41,453
Pediatrics $41,453